nodes	percent_of_prediction	percent_of_DWPC	metapath
Sufentanil—CYP3A4—type 2 diabetes mellitus	0.364	1	CbGaD
Sufentanil—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0576	0.152	CbGbCtD
Sufentanil—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0514	0.136	CbGbCtD
Sufentanil—CYP3A4—Glipizide—type 2 diabetes mellitus	0.047	0.124	CbGbCtD
Sufentanil—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0411	0.109	CbGbCtD
Sufentanil—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0371	0.0982	CbGbCtD
Sufentanil—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0282	0.0744	CbGbCtD
Sufentanil—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.027	0.0713	CbGbCtD
Sufentanil—CYP3A4—Orlistat—type 2 diabetes mellitus	0.027	0.0713	CbGbCtD
Sufentanil—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.0255	0.0675	CbGbCtD
Sufentanil—CYP3A4—Glyburide—type 2 diabetes mellitus	0.019	0.0503	CbGbCtD
Sufentanil—CYP3A4—Losartan—type 2 diabetes mellitus	0.0174	0.046	CbGbCtD
Sufentanil—Anaphylactic shock—Linagliptin—type 2 diabetes mellitus	0.00118	0.00662	CcSEcCtD
Sufentanil—Erythema—Repaglinide—type 2 diabetes mellitus	0.00117	0.00657	CcSEcCtD
Sufentanil—Bradycardia—Glimepiride—type 2 diabetes mellitus	0.00106	0.00593	CcSEcCtD
Sufentanil—Urinary tract disorder—Pioglitazone—type 2 diabetes mellitus	0.00105	0.00591	CcSEcCtD
Sufentanil—Urethral disorder—Pioglitazone—type 2 diabetes mellitus	0.00105	0.00586	CcSEcCtD
Sufentanil—Urinary tract disorder—Sitagliptin—type 2 diabetes mellitus	0.00102	0.00574	CcSEcCtD
Sufentanil—Urethral disorder—Sitagliptin—type 2 diabetes mellitus	0.00102	0.00569	CcSEcCtD
Sufentanil—Hypertension—Repaglinide—type 2 diabetes mellitus	0.00101	0.00567	CcSEcCtD
Sufentanil—Chills—Glipizide—type 2 diabetes mellitus	0.001	0.0056	CcSEcCtD
Sufentanil—Arrhythmia—Glipizide—type 2 diabetes mellitus	0.000996	0.00558	CcSEcCtD
Sufentanil—Feeling abnormal—Tolazamide—type 2 diabetes mellitus	0.000984	0.00551	CcSEcCtD
Sufentanil—Erythema—Glipizide—type 2 diabetes mellitus	0.00097	0.00544	CcSEcCtD
Sufentanil—Anaphylactic shock—Repaglinide—type 2 diabetes mellitus	0.000957	0.00536	CcSEcCtD
Sufentanil—Hypertension—Rosiglitazone—type 2 diabetes mellitus	0.000957	0.00536	CcSEcCtD
Sufentanil—Bradycardia—Bromocriptine—type 2 diabetes mellitus	0.000955	0.00535	CcSEcCtD
Sufentanil—Arrhythmia—Glimepiride—type 2 diabetes mellitus	0.000929	0.00521	CcSEcCtD
Sufentanil—Pruritus—Tolbutamide—type 2 diabetes mellitus	0.000928	0.0052	CcSEcCtD
Sufentanil—Rash—Miglitol—type 2 diabetes mellitus	0.00092	0.00515	CcSEcCtD
Sufentanil—Dermatitis—Miglitol—type 2 diabetes mellitus	0.000919	0.00515	CcSEcCtD
Sufentanil—Erythema—Glimepiride—type 2 diabetes mellitus	0.000906	0.00507	CcSEcCtD
Sufentanil—Anaphylactic shock—Rosiglitazone—type 2 diabetes mellitus	0.000905	0.00507	CcSEcCtD
Sufentanil—Hypersensitivity—Linagliptin—type 2 diabetes mellitus	0.00087	0.00488	CcSEcCtD
Sufentanil—Nausea—Miglitol—type 2 diabetes mellitus	0.000867	0.00486	CcSEcCtD
Sufentanil—Bronchospasm—Orlistat—type 2 diabetes mellitus	0.000859	0.00481	CcSEcCtD
Sufentanil—Hypersensitivity—Acarbose—type 2 diabetes mellitus	0.000845	0.00473	CcSEcCtD
Sufentanil—Pruritus—Chlorpropamide—type 2 diabetes mellitus	0.000845	0.00473	CcSEcCtD
Sufentanil—Pruritus—Tolazamide—type 2 diabetes mellitus	0.000845	0.00473	CcSEcCtD
Sufentanil—Arrhythmia—Bromocriptine—type 2 diabetes mellitus	0.000838	0.0047	CcSEcCtD
Sufentanil—Hypertension—Glipizide—type 2 diabetes mellitus	0.000838	0.00469	CcSEcCtD
Sufentanil—Rash—Tolbutamide—type 2 diabetes mellitus	0.000827	0.00463	CcSEcCtD
Sufentanil—Headache—Tolbutamide—type 2 diabetes mellitus	0.000822	0.00461	CcSEcCtD
Sufentanil—Hypersensitivity—Nateglinide—type 2 diabetes mellitus	0.000815	0.00456	CcSEcCtD
Sufentanil—Hypertension—Pioglitazone—type 2 diabetes mellitus	0.000803	0.0045	CcSEcCtD
Sufentanil—Confusional state—Glipizide—type 2 diabetes mellitus	0.000799	0.00447	CcSEcCtD
Sufentanil—Dizziness—Chlorpropamide—type 2 diabetes mellitus	0.000789	0.00442	CcSEcCtD
Sufentanil—Dizziness—Tolazamide—type 2 diabetes mellitus	0.000789	0.00442	CcSEcCtD
Sufentanil—Bradycardia—Gliclazide—type 2 diabetes mellitus	0.000784	0.00439	CcSEcCtD
Sufentanil—Pruritus—Nateglinide—type 2 diabetes mellitus	0.000782	0.00438	CcSEcCtD
Sufentanil—Hypertension—Glimepiride—type 2 diabetes mellitus	0.000782	0.00438	CcSEcCtD
Sufentanil—Nausea—Tolbutamide—type 2 diabetes mellitus	0.000779	0.00437	CcSEcCtD
Sufentanil—Hypertension—Sitagliptin—type 2 diabetes mellitus	0.000779	0.00437	CcSEcCtD
Sufentanil—Vomiting—Chlorpropamide—type 2 diabetes mellitus	0.000759	0.00425	CcSEcCtD
Sufentanil—Anaphylactic shock—Pioglitazone—type 2 diabetes mellitus	0.000759	0.00425	CcSEcCtD
Sufentanil—Rash—Chlorpropamide—type 2 diabetes mellitus	0.000753	0.00422	CcSEcCtD
Sufentanil—Rash—Tolazamide—type 2 diabetes mellitus	0.000753	0.00422	CcSEcCtD
Sufentanil—Headache—Tolazamide—type 2 diabetes mellitus	0.000748	0.00419	CcSEcCtD
Sufentanil—Headache—Chlorpropamide—type 2 diabetes mellitus	0.000748	0.00419	CcSEcCtD
Sufentanil—Erythema—Glyburide—type 2 diabetes mellitus	0.000747	0.00418	CcSEcCtD
Sufentanil—Confusional state—Glimepiride—type 2 diabetes mellitus	0.000745	0.00417	CcSEcCtD
Sufentanil—Rash—Linagliptin—type 2 diabetes mellitus	0.000745	0.00417	CcSEcCtD
Sufentanil—Dermatitis—Linagliptin—type 2 diabetes mellitus	0.000744	0.00417	CcSEcCtD
Sufentanil—Headache—Linagliptin—type 2 diabetes mellitus	0.00074	0.00415	CcSEcCtD
Sufentanil—Anaphylactic shock—Glimepiride—type 2 diabetes mellitus	0.000739	0.00414	CcSEcCtD
Sufentanil—Anaphylactic shock—Sitagliptin—type 2 diabetes mellitus	0.000737	0.00413	CcSEcCtD
Sufentanil—Dizziness—Nateglinide—type 2 diabetes mellitus	0.000731	0.0041	CcSEcCtD
Sufentanil—Vomiting—Acarbose—type 2 diabetes mellitus	0.000729	0.00409	CcSEcCtD
Sufentanil—Rash—Acarbose—type 2 diabetes mellitus	0.000723	0.00405	CcSEcCtD
Sufentanil—Dermatitis—Acarbose—type 2 diabetes mellitus	0.000722	0.00405	CcSEcCtD
Sufentanil—Tachycardia—Glimepiride—type 2 diabetes mellitus	0.000721	0.00404	CcSEcCtD
Sufentanil—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.000709	0.00397	CcSEcCtD
Sufentanil—Nausea—Tolazamide—type 2 diabetes mellitus	0.000709	0.00397	CcSEcCtD
Sufentanil—Hypertension—Bromocriptine—type 2 diabetes mellitus	0.000705	0.00395	CcSEcCtD
Sufentanil—Hypersensitivity—Repaglinide—type 2 diabetes mellitus	0.000705	0.00395	CcSEcCtD
Sufentanil—Somnolence—Glipizide—type 2 diabetes mellitus	0.000704	0.00394	CcSEcCtD
Sufentanil—Vomiting—Nateglinide—type 2 diabetes mellitus	0.000703	0.00394	CcSEcCtD
Sufentanil—Urinary tract disorder—Valsartan—type 2 diabetes mellitus	0.000699	0.00392	CcSEcCtD
Sufentanil—Rash—Nateglinide—type 2 diabetes mellitus	0.000697	0.00391	CcSEcCtD
Sufentanil—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.000697	0.0039	CcSEcCtD
Sufentanil—Urethral disorder—Valsartan—type 2 diabetes mellitus	0.000694	0.00389	CcSEcCtD
Sufentanil—Chills—Gliclazide—type 2 diabetes mellitus	0.000691	0.00387	CcSEcCtD
Sufentanil—Urinary tract disorder—Orlistat—type 2 diabetes mellitus	0.000691	0.00387	CcSEcCtD
Sufentanil—Hypotension—Glimepiride—type 2 diabetes mellitus	0.000691	0.00387	CcSEcCtD
Sufentanil—Arrhythmia—Gliclazide—type 2 diabetes mellitus	0.000688	0.00386	CcSEcCtD
Sufentanil—Urethral disorder—Orlistat—type 2 diabetes mellitus	0.000686	0.00384	CcSEcCtD
Sufentanil—Nausea—Acarbose—type 2 diabetes mellitus	0.000681	0.00382	CcSEcCtD
Sufentanil—Pruritus—Repaglinide—type 2 diabetes mellitus	0.000677	0.00379	CcSEcCtD
Sufentanil—Confusional state—Bromocriptine—type 2 diabetes mellitus	0.000672	0.00377	CcSEcCtD
Sufentanil—Erythema—Gliclazide—type 2 diabetes mellitus	0.000671	0.00376	CcSEcCtD
Sufentanil—Somnolence—Glimepiride—type 2 diabetes mellitus	0.000657	0.00368	CcSEcCtD
Sufentanil—Nausea—Nateglinide—type 2 diabetes mellitus	0.000657	0.00368	CcSEcCtD
Sufentanil—Bradycardia—Metformin—type 2 diabetes mellitus	0.000656	0.00368	CcSEcCtD
Sufentanil—Somnolence—Sitagliptin—type 2 diabetes mellitus	0.000655	0.00367	CcSEcCtD
Sufentanil—Feeling abnormal—Glipizide—type 2 diabetes mellitus	0.000653	0.00366	CcSEcCtD
Sufentanil—Tachycardia—Bromocriptine—type 2 diabetes mellitus	0.000651	0.00365	CcSEcCtD
Sufentanil—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.00064	0.00359	CcSEcCtD
Sufentanil—Feeling abnormal—Pioglitazone—type 2 diabetes mellitus	0.000625	0.0035	CcSEcCtD
Sufentanil—Hypotension—Bromocriptine—type 2 diabetes mellitus	0.000623	0.00349	CcSEcCtD
Sufentanil—Bradycardia—Irbesartan—type 2 diabetes mellitus	0.000619	0.00347	CcSEcCtD
Sufentanil—Confusional state—Glyburide—type 2 diabetes mellitus	0.000615	0.00344	CcSEcCtD
Sufentanil—Feeling abnormal—Glimepiride—type 2 diabetes mellitus	0.000609	0.00341	CcSEcCtD
Sufentanil—Vomiting—Repaglinide—type 2 diabetes mellitus	0.000609	0.00341	CcSEcCtD
Sufentanil—Feeling abnormal—Sitagliptin—type 2 diabetes mellitus	0.000607	0.0034	CcSEcCtD
Sufentanil—Rash—Repaglinide—type 2 diabetes mellitus	0.000604	0.00338	CcSEcCtD
Sufentanil—Bronchospasm—Ramipril—type 2 diabetes mellitus	0.000603	0.00338	CcSEcCtD
Sufentanil—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000603	0.00338	CcSEcCtD
Sufentanil—Urinary tract disorder—Irbesartan—type 2 diabetes mellitus	0.000601	0.00337	CcSEcCtD
Sufentanil—Headache—Repaglinide—type 2 diabetes mellitus	0.0006	0.00336	CcSEcCtD
Sufentanil—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000598	0.00335	CcSEcCtD
Sufentanil—Urethral disorder—Irbesartan—type 2 diabetes mellitus	0.000596	0.00334	CcSEcCtD
Sufentanil—Somnolence—Bromocriptine—type 2 diabetes mellitus	0.000593	0.00332	CcSEcCtD
Sufentanil—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.000583	0.00327	CcSEcCtD
Sufentanil—Hypertension—Gliclazide—type 2 diabetes mellitus	0.000579	0.00324	CcSEcCtD
Sufentanil—Chills—Metformin—type 2 diabetes mellitus	0.000578	0.00324	CcSEcCtD
Sufentanil—Rash—Rosiglitazone—type 2 diabetes mellitus	0.00057	0.0032	CcSEcCtD
Sufentanil—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.00057	0.00319	CcSEcCtD
Sufentanil—Hypotension—Glyburide—type 2 diabetes mellitus	0.00057	0.00319	CcSEcCtD
Sufentanil—Nausea—Repaglinide—type 2 diabetes mellitus	0.000569	0.00319	CcSEcCtD
Sufentanil—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000567	0.00318	CcSEcCtD
Sufentanil—Erythema—Metformin—type 2 diabetes mellitus	0.000561	0.00314	CcSEcCtD
Sufentanil—Pruritus—Glipizide—type 2 diabetes mellitus	0.00056	0.00314	CcSEcCtD
Sufentanil—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000559	0.00313	CcSEcCtD
Sufentanil—Alfentanil—CYP3A4—type 2 diabetes mellitus	0.000557	0.447	CrCbGaD
Sufentanil—Confusional state—Gliclazide—type 2 diabetes mellitus	0.000552	0.00309	CcSEcCtD
Sufentanil—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	0.000549	0.00308	CcSEcCtD
Sufentanil—Chills—Irbesartan—type 2 diabetes mellitus	0.000546	0.00306	CcSEcCtD
Sufentanil—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000544	0.00305	CcSEcCtD
Sufentanil—Arrhythmia—Irbesartan—type 2 diabetes mellitus	0.000543	0.00304	CcSEcCtD
Sufentanil—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000543	0.00304	CcSEcCtD
Sufentanil—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000537	0.00301	CcSEcCtD
Sufentanil—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.000534	0.00299	CcSEcCtD
Sufentanil—Erythema—Irbesartan—type 2 diabetes mellitus	0.000529	0.00297	CcSEcCtD
Sufentanil—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.000527	0.00295	CcSEcCtD
Sufentanil—Dizziness—Glipizide—type 2 diabetes mellitus	0.000524	0.00293	CcSEcCtD
Sufentanil—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000523	0.00293	CcSEcCtD
Sufentanil—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000511	0.00287	CcSEcCtD
Sufentanil—Arrhythmia—Losartan—type 2 diabetes mellitus	0.000511	0.00286	CcSEcCtD
Sufentanil—Vomiting—Glipizide—type 2 diabetes mellitus	0.000504	0.00282	CcSEcCtD
Sufentanil—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.000503	0.00282	CcSEcCtD
Sufentanil—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000502	0.00281	CcSEcCtD
Sufentanil—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000502	0.00281	CcSEcCtD
Sufentanil—Rash—Glipizide—type 2 diabetes mellitus	0.000499	0.0028	CcSEcCtD
Sufentanil—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000499	0.00279	CcSEcCtD
Sufentanil—Erythema—Losartan—type 2 diabetes mellitus	0.000498	0.00279	CcSEcCtD
Sufentanil—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000497	0.00278	CcSEcCtD
Sufentanil—Headache—Glipizide—type 2 diabetes mellitus	0.000496	0.00278	CcSEcCtD
Sufentanil—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000489	0.00274	CcSEcCtD
Sufentanil—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000487	0.00273	CcSEcCtD
Sufentanil—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000487	0.00273	CcSEcCtD
Sufentanil—Alfentanil—ALB—type 2 diabetes mellitus	0.000486	0.39	CrCbGaD
Sufentanil—Hypertension—Metformin—type 2 diabetes mellitus	0.000484	0.00271	CcSEcCtD
Sufentanil—Headache—Pioglitazone—type 2 diabetes mellitus	0.000475	0.00266	CcSEcCtD
Sufentanil—Nausea—Glipizide—type 2 diabetes mellitus	0.00047	0.00264	CcSEcCtD
Sufentanil—Vomiting—Glimepiride—type 2 diabetes mellitus	0.00047	0.00263	CcSEcCtD
Sufentanil—Hypotension—Valsartan—type 2 diabetes mellitus	0.00047	0.00263	CcSEcCtD
Sufentanil—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000468	0.00262	CcSEcCtD
Sufentanil—Rash—Glimepiride—type 2 diabetes mellitus	0.000466	0.00261	CcSEcCtD
Sufentanil—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000466	0.00261	CcSEcCtD
Sufentanil—Rash—Sitagliptin—type 2 diabetes mellitus	0.000465	0.0026	CcSEcCtD
Sufentanil—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000464	0.0026	CcSEcCtD
Sufentanil—Headache—Glimepiride—type 2 diabetes mellitus	0.000463	0.00259	CcSEcCtD
Sufentanil—Headache—Sitagliptin—type 2 diabetes mellitus	0.000462	0.00259	CcSEcCtD
Sufentanil—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000457	0.00256	CcSEcCtD
Sufentanil—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000451	0.00253	CcSEcCtD
Sufentanil—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000449	0.00252	CcSEcCtD
Sufentanil—Somnolence—Valsartan—type 2 diabetes mellitus	0.000447	0.0025	CcSEcCtD
Sufentanil—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000441	0.00247	CcSEcCtD
Sufentanil—Nausea—Glimepiride—type 2 diabetes mellitus	0.000439	0.00246	CcSEcCtD
Sufentanil—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.000438	0.00246	CcSEcCtD
Sufentanil—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000438	0.00245	CcSEcCtD
Sufentanil—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000433	0.00242	CcSEcCtD
Sufentanil—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000432	0.00242	CcSEcCtD
Sufentanil—Pruritus—Glyburide—type 2 diabetes mellitus	0.000431	0.00242	CcSEcCtD
Sufentanil—Hypotension—Metformin—type 2 diabetes mellitus	0.000428	0.0024	CcSEcCtD
Sufentanil—Erythema—Ramipril—type 2 diabetes mellitus	0.000427	0.00239	CcSEcCtD
Sufentanil—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000424	0.00237	CcSEcCtD
Sufentanil—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000422	0.00236	CcSEcCtD
Sufentanil—Rash—Bromocriptine—type 2 diabetes mellitus	0.00042	0.00236	CcSEcCtD
Sufentanil—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.00042	0.00235	CcSEcCtD
Sufentanil—Headache—Bromocriptine—type 2 diabetes mellitus	0.000418	0.00234	CcSEcCtD
Sufentanil—Confusional state—Losartan—type 2 diabetes mellitus	0.00041	0.0023	CcSEcCtD
Sufentanil—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000409	0.00229	CcSEcCtD
Sufentanil—Somnolence—Metformin—type 2 diabetes mellitus	0.000407	0.00228	CcSEcCtD
Sufentanil—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000407	0.00228	CcSEcCtD
Sufentanil—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000404	0.00226	CcSEcCtD
Sufentanil—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000403	0.00226	CcSEcCtD
Sufentanil—Tachycardia—Losartan—type 2 diabetes mellitus	0.000397	0.00222	CcSEcCtD
Sufentanil—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000396	0.00222	CcSEcCtD
Sufentanil—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000393	0.0022	CcSEcCtD
Sufentanil—Vomiting—Glyburide—type 2 diabetes mellitus	0.000388	0.00217	CcSEcCtD
Sufentanil—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000387	0.00217	CcSEcCtD
Sufentanil—Rash—Glyburide—type 2 diabetes mellitus	0.000384	0.00215	CcSEcCtD
Sufentanil—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000384	0.00215	CcSEcCtD
Sufentanil—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000384	0.00215	CcSEcCtD
Sufentanil—Headache—Glyburide—type 2 diabetes mellitus	0.000382	0.00214	CcSEcCtD
Sufentanil—Hypotension—Losartan—type 2 diabetes mellitus	0.00038	0.00213	CcSEcCtD
Sufentanil—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000377	0.00211	CcSEcCtD
Sufentanil—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.00037	0.00208	CcSEcCtD
Sufentanil—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000366	0.00205	CcSEcCtD
Sufentanil—Nausea—Glyburide—type 2 diabetes mellitus	0.000362	0.00203	CcSEcCtD
Sufentanil—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000362	0.00203	CcSEcCtD
Sufentanil—Somnolence—Losartan—type 2 diabetes mellitus	0.000362	0.00203	CcSEcCtD
Sufentanil—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000356	0.00199	CcSEcCtD
Sufentanil—Pruritus—Valsartan—type 2 diabetes mellitus	0.000356	0.00199	CcSEcCtD
Sufentanil—Confusional state—Ramipril—type 2 diabetes mellitus	0.000352	0.00197	CcSEcCtD
Sufentanil—Pruritus—Orlistat—type 2 diabetes mellitus	0.000352	0.00197	CcSEcCtD
Sufentanil—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000349	0.00195	CcSEcCtD
Sufentanil—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000348	0.00195	CcSEcCtD
Sufentanil—Rash—Gliclazide—type 2 diabetes mellitus	0.000345	0.00193	CcSEcCtD
Sufentanil—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000345	0.00193	CcSEcCtD
Sufentanil—Headache—Gliclazide—type 2 diabetes mellitus	0.000343	0.00192	CcSEcCtD
Sufentanil—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000342	0.00191	CcSEcCtD
Sufentanil—Tachycardia—Ramipril—type 2 diabetes mellitus	0.00034	0.00191	CcSEcCtD
Sufentanil—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000335	0.00188	CcSEcCtD
Sufentanil—Dizziness—Valsartan—type 2 diabetes mellitus	0.000332	0.00186	CcSEcCtD
Sufentanil—Dizziness—Orlistat—type 2 diabetes mellitus	0.000329	0.00184	CcSEcCtD
Sufentanil—Hypotension—Ramipril—type 2 diabetes mellitus	0.000326	0.00183	CcSEcCtD
Sufentanil—Nausea—Gliclazide—type 2 diabetes mellitus	0.000325	0.00182	CcSEcCtD
Sufentanil—Pruritus—Metformin—type 2 diabetes mellitus	0.000324	0.00181	CcSEcCtD
Sufentanil—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000321	0.0018	CcSEcCtD
Sufentanil—Vomiting—Valsartan—type 2 diabetes mellitus	0.00032	0.00179	CcSEcCtD
Sufentanil—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000318	0.00178	CcSEcCtD
Sufentanil—Rash—Valsartan—type 2 diabetes mellitus	0.000317	0.00178	CcSEcCtD
Sufentanil—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000317	0.00177	CcSEcCtD
Sufentanil—Vomiting—Orlistat—type 2 diabetes mellitus	0.000316	0.00177	CcSEcCtD
Sufentanil—Headache—Valsartan—type 2 diabetes mellitus	0.000315	0.00176	CcSEcCtD
Sufentanil—Rash—Orlistat—type 2 diabetes mellitus	0.000313	0.00176	CcSEcCtD
Sufentanil—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000313	0.00175	CcSEcCtD
Sufentanil—Headache—Orlistat—type 2 diabetes mellitus	0.000311	0.00174	CcSEcCtD
Sufentanil—Somnolence—Ramipril—type 2 diabetes mellitus	0.00031	0.00174	CcSEcCtD
Sufentanil—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000306	0.00171	CcSEcCtD
Sufentanil—Dizziness—Metformin—type 2 diabetes mellitus	0.000303	0.0017	CcSEcCtD
Sufentanil—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.0003	0.00168	CcSEcCtD
Sufentanil—Nausea—Valsartan—type 2 diabetes mellitus	0.000299	0.00167	CcSEcCtD
Sufentanil—Nausea—Orlistat—type 2 diabetes mellitus	0.000295	0.00165	CcSEcCtD
Sufentanil—Vomiting—Metformin—type 2 diabetes mellitus	0.000291	0.00163	CcSEcCtD
Sufentanil—Rash—Metformin—type 2 diabetes mellitus	0.000289	0.00162	CcSEcCtD
Sufentanil—Dermatitis—Metformin—type 2 diabetes mellitus	0.000288	0.00162	CcSEcCtD
Sufentanil—Pruritus—Losartan—type 2 diabetes mellitus	0.000288	0.00161	CcSEcCtD
Sufentanil—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000287	0.00161	CcSEcCtD
Sufentanil—Headache—Metformin—type 2 diabetes mellitus	0.000287	0.00161	CcSEcCtD
Sufentanil—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000286	0.0016	CcSEcCtD
Sufentanil—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000276	0.00154	CcSEcCtD
Sufentanil—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000275	0.00154	CcSEcCtD
Sufentanil—Rash—Irbesartan—type 2 diabetes mellitus	0.000272	0.00153	CcSEcCtD
Sufentanil—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000272	0.00152	CcSEcCtD
Sufentanil—Nausea—Metformin—type 2 diabetes mellitus	0.000272	0.00152	CcSEcCtD
Sufentanil—Headache—Irbesartan—type 2 diabetes mellitus	0.000271	0.00152	CcSEcCtD
Sufentanil—Dizziness—Losartan—type 2 diabetes mellitus	0.000269	0.00151	CcSEcCtD
Sufentanil—Vomiting—Losartan—type 2 diabetes mellitus	0.000259	0.00145	CcSEcCtD
Sufentanil—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000257	0.00144	CcSEcCtD
Sufentanil—Nausea—Irbesartan—type 2 diabetes mellitus	0.000257	0.00144	CcSEcCtD
Sufentanil—Rash—Losartan—type 2 diabetes mellitus	0.000256	0.00144	CcSEcCtD
Sufentanil—Dermatitis—Losartan—type 2 diabetes mellitus	0.000256	0.00144	CcSEcCtD
Sufentanil—Headache—Losartan—type 2 diabetes mellitus	0.000255	0.00143	CcSEcCtD
Sufentanil—Pruritus—Ramipril—type 2 diabetes mellitus	0.000247	0.00138	CcSEcCtD
Sufentanil—Nausea—Losartan—type 2 diabetes mellitus	0.000242	0.00135	CcSEcCtD
Sufentanil—Dizziness—Ramipril—type 2 diabetes mellitus	0.000231	0.00129	CcSEcCtD
Sufentanil—Vomiting—Ramipril—type 2 diabetes mellitus	0.000222	0.00124	CcSEcCtD
Sufentanil—Rash—Ramipril—type 2 diabetes mellitus	0.00022	0.00123	CcSEcCtD
Sufentanil—Dermatitis—Ramipril—type 2 diabetes mellitus	0.00022	0.00123	CcSEcCtD
Sufentanil—Headache—Ramipril—type 2 diabetes mellitus	0.000218	0.00122	CcSEcCtD
Sufentanil—Nausea—Ramipril—type 2 diabetes mellitus	0.000207	0.00116	CcSEcCtD
Sufentanil—Fentanyl—CYP3A4—type 2 diabetes mellitus	0.000204	0.164	CrCbGaD
Sufentanil—OPRD1—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	2.75e-05	0.000351	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—BHMT—type 2 diabetes mellitus	2.73e-05	0.000349	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—CCR5—type 2 diabetes mellitus	2.71e-05	0.000347	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	2.67e-05	0.000341	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	2.65e-05	0.000339	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—C3—type 2 diabetes mellitus	2.65e-05	0.000339	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—EDNRB—type 2 diabetes mellitus	2.63e-05	0.000337	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—GCG—type 2 diabetes mellitus	2.62e-05	0.000335	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—PTPN1—type 2 diabetes mellitus	2.62e-05	0.000335	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	2.6e-05	0.000332	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	2.58e-05	0.00033	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—GNB3—type 2 diabetes mellitus	2.58e-05	0.000329	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	2.57e-05	0.000329	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	2.56e-05	0.000328	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—HTR2C—type 2 diabetes mellitus	2.56e-05	0.000327	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—PSMD6—type 2 diabetes mellitus	2.56e-05	0.000327	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—MMP3—type 2 diabetes mellitus	2.54e-05	0.000325	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—AVP—type 2 diabetes mellitus	2.54e-05	0.000325	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—IGF2—type 2 diabetes mellitus	2.53e-05	0.000324	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	2.52e-05	0.000322	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—AGT—type 2 diabetes mellitus	2.52e-05	0.000322	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	2.49e-05	0.000319	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—EDNRA—type 2 diabetes mellitus	2.49e-05	0.000318	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—CALM1—type 2 diabetes mellitus	2.48e-05	0.000316	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CYBA—type 2 diabetes mellitus	2.48e-05	0.000316	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—APOB—type 2 diabetes mellitus	2.46e-05	0.000314	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—CCL2—type 2 diabetes mellitus	2.45e-05	0.000314	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	2.45e-05	0.000313	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	2.43e-05	0.000311	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—GHRL—type 2 diabetes mellitus	2.42e-05	0.00031	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—PLAT—type 2 diabetes mellitus	2.42e-05	0.00031	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—EDN1—type 2 diabetes mellitus	2.42e-05	0.000309	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—AKT2—type 2 diabetes mellitus	2.41e-05	0.000308	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	2.41e-05	0.000308	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CALCA—type 2 diabetes mellitus	2.39e-05	0.000306	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PTGDS—type 2 diabetes mellitus	2.39e-05	0.000305	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—AANAT—type 2 diabetes mellitus	2.39e-05	0.000305	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—LPL—type 2 diabetes mellitus	2.35e-05	0.0003	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	2.33e-05	0.000297	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	2.3e-05	0.000294	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	2.28e-05	0.000292	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CDO1—type 2 diabetes mellitus	2.26e-05	0.000289	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GPD2—type 2 diabetes mellitus	2.26e-05	0.000289	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—GNB3—type 2 diabetes mellitus	2.26e-05	0.000289	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	2.25e-05	0.000288	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	2.24e-05	0.000287	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—AVP—type 2 diabetes mellitus	2.23e-05	0.000285	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—MMP3—type 2 diabetes mellitus	2.23e-05	0.000285	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—IGF2—type 2 diabetes mellitus	2.22e-05	0.000284	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—GCG—type 2 diabetes mellitus	2.22e-05	0.000283	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—PTPN1—type 2 diabetes mellitus	2.22e-05	0.000283	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	2.21e-05	0.000282	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	2.2e-05	0.000281	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	2.19e-05	0.00028	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	2.18e-05	0.000279	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	2.17e-05	0.000278	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CCR5—type 2 diabetes mellitus	2.16e-05	0.000276	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—AK1—type 2 diabetes mellitus	2.16e-05	0.000276	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—APOB—type 2 diabetes mellitus	2.15e-05	0.000275	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	2.15e-05	0.000274	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—EDN1—type 2 diabetes mellitus	2.12e-05	0.000271	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—C3—type 2 diabetes mellitus	2.11e-05	0.00027	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—CCL2—type 2 diabetes mellitus	2.07e-05	0.000265	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—LPL—type 2 diabetes mellitus	2.06e-05	0.000263	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—AKT2—type 2 diabetes mellitus	2.04e-05	0.00026	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	2.04e-05	0.00026	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	2.01e-05	0.000258	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	2.01e-05	0.000257	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—IRS2—type 2 diabetes mellitus	2.01e-05	0.000257	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—AGT—type 2 diabetes mellitus	2.01e-05	0.000257	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	1.99e-05	0.000255	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	1.99e-05	0.000255	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.97e-05	0.000252	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—LEP—type 2 diabetes mellitus	1.97e-05	0.000251	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—APOE—type 2 diabetes mellitus	1.97e-05	0.000251	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.94e-05	0.000249	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	1.93e-05	0.000247	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	1.93e-05	0.000246	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	1.92e-05	0.000246	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	1.92e-05	0.000246	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	1.92e-05	0.000246	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.92e-05	0.000246	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	1.92e-05	0.000246	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—GNB3—type 2 diabetes mellitus	1.91e-05	0.000244	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.9e-05	0.000242	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—AVP—type 2 diabetes mellitus	1.88e-05	0.000241	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—MMP3—type 2 diabetes mellitus	1.88e-05	0.000241	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—IGF2—type 2 diabetes mellitus	1.88e-05	0.00024	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	1.87e-05	0.000239	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	1.86e-05	0.000238	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.85e-05	0.000237	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—C3—type 2 diabetes mellitus	1.85e-05	0.000237	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	1.85e-05	0.000236	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—APOB—type 2 diabetes mellitus	1.82e-05	0.000233	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	1.81e-05	0.000232	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—EDN1—type 2 diabetes mellitus	1.79e-05	0.000229	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.77e-05	0.000226	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.76e-05	0.000225	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—AGT—type 2 diabetes mellitus	1.76e-05	0.000225	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	1.76e-05	0.000225	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	1.76e-05	0.000225	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.75e-05	0.000224	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—LPL—type 2 diabetes mellitus	1.74e-05	0.000222	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.73e-05	0.000221	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—LEP—type 2 diabetes mellitus	1.72e-05	0.00022	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—APOE—type 2 diabetes mellitus	1.72e-05	0.00022	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	1.71e-05	0.000219	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.7e-05	0.000218	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	1.7e-05	0.000218	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—INS—type 2 diabetes mellitus	1.68e-05	0.000215	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.65e-05	0.000211	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	1.64e-05	0.000209	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	1.64e-05	0.000209	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	1.64e-05	0.000209	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	1.63e-05	0.000209	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.63e-05	0.000208	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.63e-05	0.000208	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.62e-05	0.000208	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.62e-05	0.000207	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.6e-05	0.000205	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	1.57e-05	0.0002	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	1.57e-05	0.0002	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—C3—type 2 diabetes mellitus	1.57e-05	0.0002	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.54e-05	0.000197	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.54e-05	0.000197	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	1.51e-05	0.000193	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	1.51e-05	0.000193	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.49e-05	0.000191	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.49e-05	0.00019	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—AGT—type 2 diabetes mellitus	1.49e-05	0.00019	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	1.48e-05	0.00019	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.47e-05	0.000188	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.47e-05	0.000188	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—INS—type 2 diabetes mellitus	1.47e-05	0.000188	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.46e-05	0.000187	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	1.46e-05	0.000186	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	1.46e-05	0.000186	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	1.46e-05	0.000186	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—LEP—type 2 diabetes mellitus	1.46e-05	0.000186	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—APOE—type 2 diabetes mellitus	1.46e-05	0.000186	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.45e-05	0.000185	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.44e-05	0.000184	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.43e-05	0.000182	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.42e-05	0.000182	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.42e-05	0.000181	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—RELA—type 2 diabetes mellitus	1.39e-05	0.000177	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.37e-05	0.000176	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	1.37e-05	0.000175	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.35e-05	0.000173	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.3e-05	0.000166	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.29e-05	0.000165	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.29e-05	0.000165	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	1.28e-05	0.000164	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.26e-05	0.000161	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.25e-05	0.00016	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—INS—type 2 diabetes mellitus	1.25e-05	0.000159	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.24e-05	0.000159	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	1.24e-05	0.000158	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	1.24e-05	0.000158	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	1.24e-05	0.000158	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	1.24e-05	0.000158	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.23e-05	0.000157	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—RELA—type 2 diabetes mellitus	1.22e-05	0.000155	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.2e-05	0.000154	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.2e-05	0.000154	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.2e-05	0.000153	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	1.19e-05	0.000152	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.18e-05	0.000151	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.17e-05	0.000149	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.15e-05	0.000147	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.14e-05	0.000146	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.11e-05	0.000142	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	1.11e-05	0.000141	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.1e-05	0.00014	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.09e-05	0.00014	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.09e-05	0.00014	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—SRC—type 2 diabetes mellitus	1.09e-05	0.000139	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.09e-05	0.000139	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.06e-05	0.000136	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.04e-05	0.000132	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	1.03e-05	0.000132	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—RELA—type 2 diabetes mellitus	1.03e-05	0.000131	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.03e-05	0.000131	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	1.01e-05	0.000129	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	1.01e-05	0.000129	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.01e-05	0.000129	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	9.91e-06	0.000127	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	9.85e-06	0.000126	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	9.85e-06	0.000126	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	9.85e-06	0.000126	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	9.79e-06	0.000125	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	9.74e-06	0.000125	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	9.61e-06	0.000123	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—SRC—type 2 diabetes mellitus	9.56e-06	0.000122	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.55e-06	0.000122	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	9.5e-06	0.000121	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	9.36e-06	0.00012	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	9.31e-06	0.000119	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CASP3—type 2 diabetes mellitus	9.27e-06	0.000118	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—IL6—type 2 diabetes mellitus	9.21e-06	0.000118	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	8.83e-06	0.000113	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	8.83e-06	0.000113	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	8.83e-06	0.000113	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—MMP9—type 2 diabetes mellitus	8.76e-06	0.000112	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	8.67e-06	0.000111	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	8.67e-06	0.000111	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	8.59e-06	0.00011	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.54e-06	0.000109	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	8.5e-06	0.000109	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	8.41e-06	0.000107	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—EGFR—type 2 diabetes mellitus	8.38e-06	0.000107	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	8.08e-06	0.000103	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—SRC—type 2 diabetes mellitus	8.08e-06	0.000103	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	7.99e-06	0.000102	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	7.99e-06	0.000102	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	7.87e-06	0.000101	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	7.66e-06	9.79e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	7.66e-06	9.79e-05	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—IL6—type 2 diabetes mellitus	7.34e-06	9.38e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.22e-06	9.23e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—EGFR—type 2 diabetes mellitus	7.08e-06	9.05e-05	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.77e-06	8.66e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	6.6e-06	8.44e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	6.6e-06	8.44e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	6.57e-06	8.4e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	6.48e-06	8.29e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—IL6—type 2 diabetes mellitus	6.44e-06	8.23e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	6.29e-06	8.05e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	6.12e-06	7.83e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	6.01e-06	7.68e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.94e-06	7.59e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	5.88e-06	7.52e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	5.86e-06	7.5e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	5.71e-06	7.3e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	5.64e-06	7.21e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—IL6—type 2 diabetes mellitus	5.44e-06	6.95e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	5.41e-06	6.92e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	5.31e-06	6.79e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	5.14e-06	6.57e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	5.06e-06	6.46e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	5.04e-06	6.44e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.02e-06	6.42e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	4.98e-06	6.37e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	4.39e-06	5.61e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	4.3e-06	5.5e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	3.95e-06	5.04e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	3.77e-06	4.82e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	3.77e-06	4.82e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	3.45e-06	4.41e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	1.74e-06	2.22e-05	CbGpPWpGaD
